Ítem
Solo Metadatos
SAT0118 Calprotectin stratifies disease activity better than acute phase reactants in rheumatoid arthritis patients receiving TNF inhibitors
Título de la revista
Autores
Inciarte-Mundo, J.
Hernández, M.
Ruiz-Esquide, V.
Ramírez, J.
Cuervo, A.
Amaya, J.
Pascal, M.
Yagüe, J.
Cañete, J.
Sanmarti, R.
Fecha
2015-06
Directores
ISSN de la revista
Título del volumen
Editor
BMJ Publishing Group
Buscar en:
Métricas alternativas
Resumen
Abstract
Background Calprotectin is a major S100 leucocyte protein, associated with disease activity in rheumatoid arthritis (RA) patients. Calprotectin is a potentially biomarker more sensitive of disease activity than conventional acute-phase reactans.
Palabras clave
Keywords
Calprotectin , leucocyte protein , rheumatoid arthritis , patients
